|
Business Combinations - Catalyst Merger (Details) (USD $)
|
0 Months Ended |
12 Months Ended |
|
|
Jul. 02, 2012
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Jul. 02, 2012
|
| Merger Agreement [Abstract] |
|
|
|
|
|
| Amortization of intangible assets |
|
$ 213,220,000 |
$ 203,192,000 |
$ 130,116,000 |
|
| Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract] |
|
|
|
|
|
| Goodwill |
|
4,724,639,000 |
4,720,275,000 |
4,478,038,000 |
|
| Common Shares |
|
|
|
|
|
| Merger Agreement [Abstract] |
|
|
|
|
|
| Public offering, shares of common stock |
|
|
|
11,960,000 |
|
| Catalyst |
|
|
|
|
|
| Merger Agreement [Abstract] |
|
|
|
|
|
| Goodwill expected to be tax deductible |
525,000,000 |
|
|
|
525,000,000 |
| Amortization of intangible assets |
|
154,700,000 |
166,100,000 |
|
|
| Fair value of intangible assets |
1,200,000,000 |
|
|
|
|
| Customer relationships, weighted average useful life |
|
9 years |
|
|
|
| Business Combination, Consideration Transferred [Abstract] |
|
|
|
|
|
| Fair value of common shares issued |
3,238,141,000 |
|
|
|
|
| Fair value of warrants and stock options issued |
19,824,000 |
|
|
|
|
| Total purchase price |
4,673,241,000 |
|
|
|
|
| Separate Tranactions and Preexisting Relationships [Abstract] |
|
|
|
|
|
| Transaction and integration expense |
|
|
|
27,200,000 |
|
| Business Combination, Transaction Expense |
|
|
|
22,800,000 |
|
| Acquisition costs included in selling, general and administrative expenses |
|
|
|
17,000,000 |
|
| Contract settlements and termination charges recorded |
|
|
|
3,500,000 |
|
| Accounts receivable with acquired business |
|
|
|
4,100,000 |
|
| Catalyst | Common Shares |
|
|
|
|
|
| Merger Agreement [Abstract] |
|
|
|
|
|
| Stock conversion, share received per share converted |
1.3212 |
|
|
|
1.3212 |
| Stock conversion, cash received per share converted, prior to stock split |
0.6606 |
|
|
|
0.6606 |
| Stock conversion, cash received per share converted |
$ 28.00 |
|
|
|
$ 28.00 |
| Public offering, shares of common stock |
66,800,000 |
|
|
|
|
| Warrants, Issued |
500,000 |
|
|
|
|
| Business Combination, Consideration Transferred [Abstract] |
|
|
|
|
|
| Cash paid to shareholders |
1,415,276,000 |
|
|
|
|
| Catalyst | Initial Amounts Recognized at Acquisition Date |
|
|
|
|
|
| Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract] |
|
|
|
|
|
| Cash and cash equivalents |
93,775,000 |
|
|
|
93,775,000 |
| Other current assets |
695,888,000 |
|
|
|
695,888,000 |
| Total current assets |
789,663,000 |
|
|
|
789,663,000 |
| Goodwill |
4,010,235,000 |
|
|
|
4,010,235,000 |
| Customer relationships intangible |
1,184,800,000 |
|
|
|
1,184,800,000 |
| Other long-term assets |
87,174,000 |
|
|
|
87,174,000 |
| Total assets acquired |
6,071,872,000 |
|
|
|
6,071,872,000 |
| Accounts payable |
338,819,000 |
|
|
|
338,819,000 |
| Pharmacy benefit management rebates payable |
176,202,000 |
|
|
|
176,202,000 |
| Accrued expenses and other current liabilities |
187,851,000 |
|
|
|
187,851,000 |
| Long-term debt |
311,994,000 |
|
|
|
311,994,000 |
| Other long-term liabilities |
385,375,000 |
|
|
|
385,375,000 |
| Total liabilities assumed |
1,400,241,000 |
|
|
|
1,400,241,000 |
| Non-controlling interest |
(1,610,000) |
|
|
|
(1,610,000) |
| Net assets acquired |
4,673,241,000 |
|
|
|
4,673,241,000 |
| Catalyst | Measurement Period Adjustments |
|
|
|
|
|
| Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract] |
|
|
|
|
|
| Cash and cash equivalents |
|
|
0 |
(315,000) |
|
| Other current assets |
|
|
2,411,000 |
5,202,000 |
|
| Total current assets |
|
|
2,411,000 |
4,887,000 |
|
| Goodwill |
|
|
16,141,000 |
8,492,000 |
|
| Customer relationships intangible |
|
|
0 |
0 |
|
| Other long-term assets |
|
|
8,000 |
1,547,000 |
|
| Total assets acquired |
|
|
18,560,000 |
14,926,000 |
|
| Accounts payable |
|
|
5,000 |
0 |
|
| Pharmacy benefit management rebates payable |
|
|
(1,522,000) |
2,935,000 |
|
| Accrued expenses and other current liabilities |
|
|
5,473,000 |
1,348,000 |
|
| Long-term debt |
|
|
0 |
0 |
|
| Other long-term liabilities |
|
|
14,604,000 |
10,643,000 |
|
| Total liabilities assumed |
|
|
18,560,000 |
14,926,000 |
|
| Non-controlling interest |
|
|
0 |
0 |
|
| Net assets acquired |
|
|
0 |
0 |
|
| Catalyst | Final Amounts Recognized at Acquisition Date |
|
|
|
|
|
| Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract] |
|
|
|
|
|
| Cash and cash equivalents |
93,460,000 |
|
|
|
93,460,000 |
| Other current assets |
703,501,000 |
|
|
|
703,501,000 |
| Total current assets |
796,961,000 |
|
|
|
796,961,000 |
| Goodwill |
4,034,868,000 |
|
|
|
4,034,868,000 |
| Customer relationships intangible |
1,184,800,000 |
|
|
|
1,184,800,000 |
| Other long-term assets |
88,729,000 |
|
|
|
88,729,000 |
| Total assets acquired |
6,105,358,000 |
|
|
|
6,105,358,000 |
| Accounts payable |
338,824,000 |
|
|
|
338,824,000 |
| Pharmacy benefit management rebates payable |
177,615,000 |
|
|
|
177,615,000 |
| Accrued expenses and other current liabilities |
194,672,000 |
|
|
|
194,672,000 |
| Long-term debt |
311,994,000 |
|
|
|
311,994,000 |
| Other long-term liabilities |
410,622,000 |
|
|
|
410,622,000 |
| Total liabilities assumed |
1,433,727,000 |
|
|
|
1,433,727,000 |
| Non-controlling interest |
(1,610,000) |
|
|
|
(1,610,000) |
| Net assets acquired |
4,673,241,000 |
|
|
|
4,673,241,000 |
| Catalyst | Employees Settlements |
|
|
|
|
|
| Separate Tranactions and Preexisting Relationships [Abstract] |
|
|
|
|
|
| Expenses and losses recognized |
|
|
|
3,100,000 |
|
| Catalyst | Severence Cost |
|
|
|
|
|
| Separate Tranactions and Preexisting Relationships [Abstract] |
|
|
|
|
|
| Expenses and losses recognized |
|
|
|
$ 10,400,000 |
|